-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on LeMaitre Vascular, Lowers Price Target to $110

Benzinga·11/05/2026 14:11:17
Listen to the news
Citizens analyst Daniel Stauder maintains LeMaitre Vascular (NASDAQ:LMAT) with a Market Outperform and lowers the price target from $127 to $110.